Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.35 USD | -6.26% | -5.17% | -27.45% |
May. 09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
May. 08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.45% | 1.1B | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Morgan Stanley Adjusts Pharvaris' Price Target to $34 From $35, Keeps Overweight Rating